دورية أكاديمية
أعرض في EDS

The course of infection with the Delta variant of COVID-19 in pregnancy: analysis of clinical, laboratory, and neonatal outcomes

التفاصيل البيبلوغرافية
العنوان: The course of infection with the Delta variant of COVID-19 in pregnancy: analysis of clinical, laboratory, and neonatal outcomes
المؤلفون: Göklü MR; Clinic of Obstetrics and Gynecology, University of Health Sciences Turkey, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey, Oğlak SC; Clinic of Obstetrics and Gynecology, University of Health Sciences Turkey, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey, Gedik Özköse Z; Clinic of Perinatology, University of Health Sciences Turkey, Kanuni Sultan Süleyman Training and Research Hospital, İstanbul, Turkey, Tunç Ş; Clinic of Obstetrics and Gynecology, University of Health Sciences Turkey, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey, Bolluk G; Clinic of Perinatology, University of Health Sciences Turkey, Başakşehir Çam and Sakura City Hospital, İstanbul, Turkey
المصدر: Journal of the Turkish German Gynecological Association [J Turk Ger Gynecol Assoc] 2023 Mar 15; Vol. 24 (1), pp. 33-41. Date of Electronic Publication: 2022 Dec 30.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Galenos Publishing House Country of Publication: Turkey NLM ID: 101272522 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1309-0399 (Print) Linking ISSN: 13090380 NLM ISO Abbreviation: J Turk Ger Gynecol Assoc Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2017- : Istanbul : Galenos Publishing House
Original Publication: Berlin : Turkish German Gynecological Association
مستخلص: Objective: This study aimed to examine the effects of infection with the Delta variant of coronavirus disease-2019 (COVID-19) on the clinical course, laboratory parameters, and neonatal outcome in pregnant women.
Material and Methods: A total of 96 pregnant women who tested positive for the Delta variant of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) causing COVID-19 were retrospectively examined. The pregnant women were divided into three groups: Asymptomatic; non-severe; and severe. Age, obstetric history, symptoms and findings, blood tests, medication and vaccination history, clinical course, and perinatal outcome of pregnant women were analyzed.
Results: Pregnant women who tested positive for the Delta variant of SARS-CoV-2 had an intensive care unit (ICU) admission rate of 9.4% and a mortality rate of 5.2%. Pregnant women in the severe disease group had significantly higher rates of preterm birth and cesarean section compared with the non-severe and asymptomatic group. Pregnant women in the severe group had high C-reactive protein (CRP) levels at the time of admission. White blood cell count (WBC) and procalcitonin levels were increased in clinical follow-up in women in the severe group.
Conclusion: The Delta variant of SARS-CoV-2 was found to increase mortality rates in pregnant women compared to pre-Delta variants of COVID-19. In pregnant women infected with the Delta variant, advanced gestational age at diagnosis, high CRP, WBC, and procalcitonin levels were significantly correlated with poor prognosis. Pregnant women infected with the Delta variant and with severe COVID-19 had an increased risk for preterm delivery and cesarean section. Although newborns of women with severe disease were found to have significantly higher rates of ICU admission, there was no significant difference in neonatal mortality rates. We recommend close monitoring of CRP, WBC, and procalcitonin levels, in addition to symptoms, in pregnant women infected with the Delta variant of SARS-CoV-2 and diagnosed in the third trimester.
Competing Interests: Conflict of Interest: No conflict of interest is declared by the authors.
(©Copyright 2023 by the Turkish-German Gynecological Education and Research Foundation - Journal of the Turkish-German Gynecological Association published by Galenos Publishing House.)
References: Front Endocrinol (Lausanne). 2021 Nov 15;12:778911. (PMID: 34867825)
Pak J Med Sci. 2021 May-Jun;37(3):863-868. (PMID: 34104179)
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9748-9752. (PMID: 33015821)
Ochsner J. 2021 Winter;21(4):364-370. (PMID: 34984051)
J Gynecol Obstet Hum Reprod. 2020 Jun;49(6):101739. (PMID: 32251738)
Am J Reprod Immunol. 2020 Nov;84(5):e13340. (PMID: 32894803)
J Obstet Gynaecol Res. 2022 Mar;48(3):647-653. (PMID: 34927322)
Obstet Gynecol. 2021 Dec 1;138(6):838-841. (PMID: 34592748)
J Obstet Gynaecol Res. 2017 Jan;43(1):23-29. (PMID: 27928862)
Obstet Gynecol. 2021 Dec 1;138(6):842-844. (PMID: 34592747)
Front Cell Infect Microbiol. 2021 Nov 23;11:771524. (PMID: 34888260)
Obstet Gynecol. 2018 Jan;131(1):e1-e14. (PMID: 29266075)
Am J Obstet Gynecol. 2022 Jan;226(1):149-151. (PMID: 34529957)
Avicenna J Med. 2021 Nov 15;11(4):200-209. (PMID: 34881203)
Clin Med (Lond). 2021 Sep;21(5):e446-e450. (PMID: 34507928)
Saudi Med J. 2022 Jun;43(6):559-566. (PMID: 35675933)
Saudi Med J. 2022 Apr;43(4):378-385. (PMID: 35414616)
Emerg Infect Dis. 2022 Feb;28(2):331-337. (PMID: 34876242)
Int J Med Sci. 2021 Jan 1;18(3):763-767. (PMID: 33437211)
Ginekol Pol. 2022 Jan 24;:. (PMID: 35072238)
Infect Dis Rep. 2021 Nov 30;13(4):993-1008. (PMID: 34940401)
Pharmacology. 2017;100(3-4):161-171. (PMID: 28641304)
Expert Rev Vaccines. 2021 Oct;20(10):1201-1209. (PMID: 34488546)
Postgrad Med J. 2021 May;97(1147):312-320. (PMID: 32978337)
Ginekol Pol. 2021;92(9):631-636. (PMID: 33844260)
BMC Pregnancy Childbirth. 2020 Mar 30;20(1):186. (PMID: 32228514)
فهرسة مساهمة: Keywords: COVID-19; delta variant; pregnancy
تواريخ الأحداث: Date Created: 20221230 Latest Revision: 20230318
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10019012
DOI: 10.4274/jtgga.galenos.2022.2022-6-8
PMID: 36583294
قاعدة البيانات: MEDLINE
الوصف
تدمد:1309-0399
DOI:10.4274/jtgga.galenos.2022.2022-6-8